BTK Inhibitors

Rhapsido is only available as a brand name drug.

ZANUBRUTINIB treats leukemia and lymphoma. It works by blocking a protein that causes cancer cells to grow and multiply. This helps to slow or stop the spread of cancer cells.

Wayrilz is part of the BTK Inhibitors class and treats Thrombocytopenia. BTK inhibitors are used to treat several types of cancer, including chronic lymphocytic leukemia and mantle cell lymphoma. Some are also used to treat conditions like ITP and chronic spontaneous urticaria. They work by blocking a protein called Bruton's tyrosine kinase (BTK), which helps certain cancer and immune cells grow and communicate. This helps slow cancer growth or reduce an overactive immune response. Wayrilz is only available as a brand name drug.

Imbruvica is part of the BTK Inhibitors class and treats Chronic Graft Versus-Host Disease and Non-Hodgkin Lymphoma. BTK inhibitors are used to treat several types of cancer, including chronic lymphocytic leukemia and mantle cell lymphoma. Some are also used to treat conditions like ITP and chronic spontaneous urticaria. They work by blocking a protein called Bruton's tyrosine kinase (BTK), which helps certain cancer and immune cells grow and communicate. This helps slow cancer growth or reduce an overactive immune response. Imbruvica is only available as a brand name drug.

ACALABRUTINIB treats leukemia and lymphoma. It works by blocking a protein that causes cancer cells to grow and multiply. This helps to slow or stop the spread of cancer cells.

PIRTOBRUTINIB treats leukemia and lymphoma. It works by blocking a protein that causes cancer cells to grow and multiply. This helps to slow or stop the spread of cancer cells.